Movement Alert｜Insilico Medicine Falls 5.43% in Regular Trading, Massive Lock-Up Expiry Countdown Compounds Life Sciences Sector Weakness

Market Focus06-09

On June 9, Insilico Medicine fell 5.43% in regular trading, trading at 33.92 HKD/share, with trading volume of 103 million HKD.

On the news front, the company's cornerstone investors and employee restricted shares lock-up period is set to expire on June 29, at which point approximately 453 million shares — representing 81.25% of total share capital — will become available for trading. Market concerns over potential selling pressure from these shareholders have intensified ongoing disposals. The stock has already seen a cumulative decline of nearly 40% over the past month amid Abu Dhabi secondary listing expectations falling through and the approaching unlock window.

Meanwhile, the Life Sciences Tools and Services sector declined broadly, with WUXI APPTEC down 6.02%, GENSCRIPT BIO down 4.80%, WUXI XDC down 4.15%, WUXI BIO down 4.08%, and XTALPI down 3.38%, amplifying the stock's losses through sector-wide selling pressure.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1128579425?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-09 11:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1128579425","market":"hk","top_or_hot":-1,"title":"Movement Alert｜Insilico Medicine Falls 5.43% in Regular Trading, Massive Lock-Up Expiry Countdown Compounds Life Sciences Sector Weakness","media":"Market Focus","content":"<p><p>On June 9, Insilico Medicine fell 5.43% in regular trading, trading at 33.92 HKD/share, with trading volume of 103 million HKD.</p><p>On the news front, the company's cornerstone investors and employee restricted shares lock-up period is set to expire on June 29, at which point approximately 453 million shares — representing 81.25% of total share capital — will become available for trading. Market concerns over potential selling pressure from these shareholders have intensified ongoing disposals. The stock has already seen a cumulative decline of nearly 40% over the past month amid Abu Dhabi secondary listing expectations falling through and the approaching unlock window.</p><p>Meanwhile, the Life Sciences Tools and Services sector declined broadly, with WUXI APPTEC down 6.02%, GENSCRIPT BIO down 4.80%, WUXI XDC down 4.15%, WUXI BIO down 4.08%, and XTALPI down 3.38%, amplifying the stock's losses through sector-wide selling pressure.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Insilico Medicine Falls 5.43% in Regular Trading, Massive Lock-Up Expiry Countdown Compounds Life Sciences Sector Weakness</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Insilico Medicine Falls 5.43% in Regular Trading, Massive Lock-Up Expiry Countdown Compounds Life Sciences Sector Weakness\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-09 11:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 9, Insilico Medicine fell 5.43% in regular trading, trading at 33.92 HKD/share, with trading volume of 103 million HKD.</p><p>On the news front, the company's cornerstone investors and employee restricted shares lock-up period is set to expire on June 29, at which point approximately 453 million shares — representing 81.25% of total share capital — will become available for trading. Market concerns over potential selling pressure from these shareholders have intensified ongoing disposals. The stock has already seen a cumulative decline of nearly 40% over the past month amid Abu Dhabi secondary listing expectations falling through and the approaching unlock window.</p><p>Meanwhile, the Life Sciences Tools and Services sector declined broadly, with WUXI APPTEC down 6.02%, GENSCRIPT BIO down 4.80%, WUXI XDC down 4.15%, WUXI BIO down 4.08%, and XTALPI down 3.38%, amplifying the stock's losses through sector-wide selling pressure.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03696","symbol_name":"英矽智能","start_time":0,"source_url":"","article_id":"1128579425","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1128579425","pubTimestamp":1780975586,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 9, Insilico Medicine fell 5.43% in regular trading, trading at 33.92 HKD/share, with trading volume of 103 million HKD.On the news front, the company's cornerstone investors and employee...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03696":"英矽智能"},"translate_title":"动向提示|英矽智能常规交易跌5.43%大规模禁售到期倒计时加剧生命科学板块疲软","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03696":1},"content_text":"On June 9, Insilico Medicine fell 5.43% in regular trading, trading at 33.92 HKD/share, with trading volume of 103 million HKD.On the news front, the company's cornerstone investors and employee restricted shares lock-up period is set to expire on June 29, at which point approximately 453 million shares — representing 81.25% of total share capital — will become available for trading. Market concerns over potential selling pressure from these shareholders have intensified ongoing disposals. The stock has already seen a cumulative decline of nearly 40% over the past month amid Abu Dhabi secondary listing expectations falling through and the approaching unlock window.Meanwhile, the Life Sciences Tools and Services sector declined broadly, with WUXI APPTEC down 6.02%, GENSCRIPT BIO down 4.80%, WUXI XDC down 4.15%, WUXI BIO down 4.08%, and XTALPI down 3.38%, amplifying the stock's losses through sector-wide selling pressure.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1128579425","isCrawlerRequest":true}